tiprankstipranks
Vyome Holdings, Inc. (HIND)
NASDAQ:HIND
US Market
HIND
Vyome Holdings
RESEARCH TOOLSreports
Want to see HIND full AI Analyst Report?

Vyome Holdings (HIND) Earnings Dates, Call Summary & Reports

630 Followers

Earnings Data

Report Date
Nov 24, 2026
Before Open (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
―
Last Year’s EPS
-3.12
Same Quarter Last Year
Analyst Consensus
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2024
Earnings Call Date:Nov 14, 2024|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted several positive achievements, such as revenue growth, cost reductions, improved profit margins, and strategic agreements aimed at enhancing shareholder value. However, it also acknowledged challenges, such as the contraction in revenue over the nine-month period and competition from GLP-1 pharmaceuticals. Overall, the positive aspects slightly outweigh the negative trends.
Company Guidance
During the third quarter of 2024, ReShape Lifesciences demonstrated significant financial and operational improvements. Revenue increased by 16.6% compared to the previous quarter and 6.4% year-over-year, marking the third consecutive quarter of growth. The company achieved a gross profit margin of 62.8% for the quarter, with a cumulative margin of 60.3% for the first nine months. Operating expenses were reduced by over 40% compared to the same period last year, and total operating costs for the first nine months were down by 41%. ReShape also reported a non-GAAP adjusted EBITDA of $1.6 million for the quarter, an improvement from a $2.9 million loss in the prior year. In addition, the company secured a supplementary NIH grant of approximately $241,000, bringing total NIH funding to $1.15 million. The company also received approval for its Lap-Band 2.0 FLEX from Health Canada, further expanding its market opportunities.
Revenue Growth
Revenue increased by 16.6% in the third quarter over the second quarter and 6.4% over the third quarter of last year.
Cost Reduction Achievements
Achieved over 40% reduction in operating expenses for the first 9 months of the year compared to last year.
Gross Profit Margin Improvement
Gross profit margin increased to 62.8% for the quarter and 60.3% for the first 9 months.
Lap-Band 2.0 FLEX Approval
Received approval for the Lap-Band 2.0 FLEX from Health Canada, supporting global regulatory efforts.
NIH Grant Award
Awarded a $241,000 supplementary grant from NIH, bringing total awards to $1.15 million.
Merger and Asset Sale Agreements
Coordinated merger agreement with Vyome Therapeutics and asset purchase agreement with Biorad, expected to maximize stockholder value.

Vyome Holdings (HIND) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
Daily Earnings Calendar >

HIND Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 24, 2026
2026 (Q3)
- / -
-3.12―――
May 28, 2026
2026 (Q1)
-0.15 / -0.15
78.083-100.19% (-78.23)――
Mar 26, 2026
2025 (Q4)
-0.47 / -0.47
-241.23999.81% (+240.77)――
Nov 18, 2025
2025 (Q3)
-0.11 / -3.12
-302.35398.97% (+299.23)―
Aug 18, 2025
2025 (Q2)
- / -9.00
-427.79697.90% (+418.80)――
May 21, 2025
2025 (Q1)
- / 18.98
-542.242103.50% (+561.22)――
Apr 07, 2025
2024 (Q4)
- / 78.08
-542.242114.40% (+620.32)―
Nov 14, 2024
2024 (Q3)
- / -302.35
-591694.89% (+5613.65)―
Aug 14, 2024
2024 (Q2)
- / -427.80
-626493.17% (+5836.20)―
May 15, 2024
2024 (Q1)
- / -
-1.402――
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

HIND Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 28, 2026
$2.24$2.35+4.91%
Mar 26, 2026
$2.27$2.20-3.08%
Nov 18, 2025
$4.88$4.97+1.84%
Aug 18, 2025
$14.00$8.73-37.64%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Vyome Holdings, Inc. (HIND) report earnings?
Vyome Holdings, Inc. (HIND) is schdueled to report earning on Nov 24, 2026, Before Open (Confirmed).
    What is Vyome Holdings, Inc. (HIND) earnings time?
    Vyome Holdings, Inc. (HIND) earnings time is at Nov 24, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is HIND EPS forecast?
          Currently, no data Available